Purchase Order HHSD2002013M57368P

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Inflexxion, Inc., a for-profit organization, to improve the quality and representativeness of the Addiction Severity Index-Multimedia Version (ASI-MV) Network. This contract, with a potential value of $1,095,103.00, is associated with the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The contract does not have a set-aside designation and...

This is a $38,403.00 Firm Fixed Price Delivery Order awarded by the Food and Drug Administration (FDA) to Denver Health and Hospital Authority, doing business as Denver Health, a comprehensive healthcare system in Denver, Colorado. The order is for a task titled "Drug Specific Report- Route of Abuse Patterns for Opana ER and Selected Comparator Opioids among Individuals Entering Treatment for Opioid Addictions." This order is placed under the FDA's Prescription Drug Abuse Summary...

The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $4,910,419.00 Cost Plus Award Fee contract to Advancement Strategy LLC, a small disadvantaged 8(a) business, to fulfill a Congressional mandate under the Sober Truth on Preventing Underage Drinking (STOP) Act. The purpose of this contract is for Advancement Strategy to produce an annual report to Congress on the national efforts to reduce underage drinking, as well as annual state-by-state reports on prevention...

The Department of Justice Drug Enforcement Administration (DEA) awarded a $136,383.00 firm fixed price purchase order to The Mclean Hospital Corporation, a non-profit research hospital affiliated with Harvard Medical School, to conduct a study on the drug discrimination and locomotor activity of 15 designer benzodiazepine substances. This study aims to gather pharmacological, medical, and epidemiological data to support the DEA's efforts to place these substances under regulatory control under...

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,292.16, is for the supply of NALTREXONE 50 MG TABLET 30S, a medication used in the treatment of opioid dependence. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...

The Defense Logistics Agency Troop Support Medical awarded a $310 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.4 mg/ml vials of naloxone. As the prime contractor, Amerisourcebergen will deliver the opioid overdose reversal medication from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by July 20, 2023. No subcontractors or set aside designations were indicated. This supports DLA's mission to provide medical supplies to the Department of...

The Defense Logistics Agency Troop Support Medical awarded a $39,570 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply naloxone hydrochloride. As part of the agency's stockpile of opioid overdose reversal medications, this order will provide the drug to address the ongoing public health emergency. DMS Pharmaceutical Group will fulfill the order from its facility in Park Ridge, Illinois by August 28, 2023. No subcontractors or set aside designations were specified. The...

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,669 to Amerisourcebergen Drug Corporation for the supply of 30 units of 8-2mg films of buprenorphine-naloxone. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on July 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this...

The Defense Logistics Agency Troop Support Medical awarded a $779,230 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply naloxone hydrochloride. As part of DLA's stockpile of essential medical supplies, this contract will provide 1,456,162 units of the opioid overdose reversal drug. No subcontractors or set aside designations were specified. DLA manages the Defense Department's global supply chain and distribution network, maintaining readiness by delivering medical...

The Defense Logistics Agency Troop Support Medical awarded a $306,660 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply naloxone hydrochloride. As part of DLA's stockpile of critical medical supplies, this order will provide 1,000 units of the opioid overdose reversal drug to address needs under the agency's chemical and biological defense program on a short timeline from July 10-11, 2023. DMS Pharma will fulfill the order from its manufacturing facility in Park Ridge,...